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The aim of this study was to reevaluate and update the followup of a previously published randomized controlled trial (RCT) on
the impact of Burch Colposuspension (BC), as an anti-incontinence procedure, in patients with UI and POP, who underwent POP
repair. Forty-seven women were randomly assigned to abdominal POP repair and concomitant BC (24 patients; group A) or POP
repair alone without any anti-incontinence procedure (23 patients; group B). Median followup was 82 months (range 60–107);
from over 47 patients, 30 reached 6-year followup. Two patients were lost at followup. In group A, 2 patients showed a stage I
rectocele. In group B, 2 patients had a stage I rectocele and 1 a stage II rectocele. In group A, 13/23 (56.5%) were still incontinent
after surgery compared with 9/22 patients (40.9%) in group B (P = 0.298). No signiﬁcant changes were observed between the
ﬁrst and the current followup. The update of long-term followup conﬁrmed that BC did not improve outcome signiﬁcantly in
incontinent women when they undergo POP repair.
1.Introduction
The prevalence of POP and UI increases with aging, and
their association is not negligible [1–3]. Urologists and gyne-
cologists have long performed POP repair in concomitance
with an anti-incontinence procedure in women with SUI
[4]. For many years, the concomitant anti-incontinence gold
standard procedure was the BC. Studies with short- and
midterm followups doubted the beneﬁt of concomitant BC
and POP repair in women with or without UI [5–8].
Thus, rigorous scientiﬁc assessment of the long-term
outcome of surgery for POP and UI is essential in order
to get an idea of what we are achieving in this ﬁeld of
non-life-threatening disease. It can be obtained by extending
followup.Long-termfollowupisthemainfactoraﬀectingthe
validity of interstudy comparisons of the eﬃcacy and safety
of treatment for POP and UI repair.
In order to evaluate the long-term impact of BC as an
anti-incontinence measure during abdominal POP repair in
patients with concomitant UI, we updated the followup of a
RCT, whose midterm outcome (three-year F-U) has already
been published [8].
2.MaterialandMethods
2.1. Study Population. The study design, inclusion and
exclusion criteria were described in detail in previous paper
[8]. To sum up, from January 2002 to June 2006, 47 women
suﬀering from POP and Stress UI were randomly assigned
to abdominal POP repair and concomitant BC (24 patients;
group A) or POP repair alone without any anti-incontinence
procedure (23 patients; group B).
All patients were assessed by means of history, clinical
examination,UDI-6andIIQ-7questionnaires,bladderdiary,2 Obstetrics and Gynecology International
urine culture, 1h pad test, and pelvic ultrasound. Vaginal
inspection was performed in the gynecological and standing
positions, at rest and under maximum straining with a
full bladder. POP was evaluated according to POP-Q systems
for quantitative description of POP. Clinical neurological
tests of the perineum and lower limbs were normal in all
patients. Urinary symptoms were recorded according to ICS
criteria [9] and split into voiding and storage symptoms.
All patients underwent urodynamic assessment, complying
with ICS standards, which consist of uroﬂowmetry, ﬁlling
cystometry, urethral pressure proﬁle, pressure-ﬂow study,
and the VLPP [10]. UI was classiﬁed clinically on the basis
of the ICS deﬁnition and graded on the Ingelman Sundberg
scale[11].Beforeandafterprolapserepositioningallpatients
underwent a stress test in the supine position at maximum
physiological bladder capacity. Patients with a negative stress
test (also called cough test) when prolapse is not corrected
but with a positive stress test when the prolapse is corrected
(masked incontinence) were considered positive.
A standard Burch procedure, using non-reabsorbable
suture, was performed as originally described [12]. The
abdominal sacropexy was performed as previously reported
[13, 14]. After entering the peritoneal cavity, the anterior
vaginal wall was dissected from the bladder as far the bladder
neck to expose a vaginal wall area of at least 3–5cm where
the mesh was attached with four polyglycolic 0 sutures. The
posterior vaginal wall was freed as far as the levator ani
plane and the mesh were attached with four polyglycolic
0 sutures. The two polypropylene prostheses were tailored
and after the sacral promontory surface was prepared were
placed in the sacral periosteum, about 2cm below the
promontory by one or two non-reabsorbable 00 sutures,
avoiding excessive traction. The peritoneum was closed over
themeshes.Whentheuterussparingsurgerywasperformed,
two proximal sutures were positioned on the anterior and
posterior cervical areas. The two polypropylene prostheses
were cut: one rectangular and one Y shaped; the right and
the left edges of the anterior Y-shaped mesh were passed
through the broad ligaments, at a nonvascular point about
1cm from the external part of the isthmus. Sacropexy or
the hysterosacropexy was the ﬁrst surgical step and BC the
second step.
2.2. Randomization Process. Patients were assigned to groups
according to a randomized computer-generated block design
provided by the Statistics Department of the University of
Perugia. Participants were intentionally allocated in equal
numbers to each intervention according to a randomization
ratio1:1.PatientsweremaskedtoBurchallocation,andinves-
tigators who operated were not blinded to group assignment.
2.3. Followup. Check-ups were scheduled at 3, 6, 9 months
postoperatively and then annually. They included a detailed
urogynaecological history, clinical examination, and stress
test. Between September and December 2010 all patients’
charts were reevaluated to update followups.
T h ep r i m a r yo u t c o m em e a s u r e sw e r e( 1 )c h a n g e si nt h e
continence status (including urgency and SUI) as indicated
by bladder diary, number of daily pads, and stress test.
Success was deﬁned as a completely dry patient: no leakage
reported in the bladder diary, no pad use, and a negative
stress test; (2) anatomical outcome of prolapse repair.
Objective success was deﬁned as the cervix/vault remaining
well supported >6cm above the hymen plane and no vaginal
prolapse greater than or equal to stage 2 at any vaginal
site while the patient performed a Valsalva maneuver. The
secondary endpoints were changes in subjective symptoms
and QoL as measured by questionnaires (IIQ-6, UDI-7). A
VAS score (0–10) was recorded to assess the postoperative
satisfaction (0 corresponded to the lowest satisfaction and
10 to the highest satisfaction with surgery). Finally, all
patientswereasked:“Wouldyourepeattheoperationagain?”
Not-masked research staﬀ people performed the followup
evaluation.
The study was registered at http://www.clinicaltrials.gov/
(Protocol ID: NCT00576004) [8].
Preliminary power analyses indicated that the samples
of 47 patients provided statistical power (1-β)o fa tl e a s t
80% at α = 0.05 for detecting 35–40% in diﬀerences of
proportion of postoperative incontinence between the two
groups, when the incidence of postoperative conditions in
group B equaled 10–30%, respectively. The Mann-Whitney
test and Wilcoxon test for paired data were used to compare
ordinal and nonnormally distributed continuous variables
(deviation from Gaussian distribution was checked by the
Kolgomorov-Smirnovtest).Categoricaldatawasanalyzedby
the McNemar test, X2 test, or Fisher’s exact test. Signiﬁcance
was set at P<0.05. Data were analyzed using PASW release
17.0.2, SPSS Inc., Chicago, USA, 2009.
3. Results
The overall median followup was 82 (range 60–107) (group
A: 82 (range 61–107) and group B: 80 (range 60–100)).
The two groups (A-B) did not diﬀer signiﬁcantly in any
demographic and clinical variable (Table 1). Urodynamic
and perioperative complications were described in a pre-
vious paper [8]. Two patients were lost at followup: one in
group A committed suicide; one in group B moved abroad
and did not attend followups anymore.
In group A 2 patients showed a stage I rectocele. In
group B 2 patients had a stage I rectocele and 1 a stage II
rectocele. Incontinence persisted in 13/23 patients (56.5%)
in group A and in 9/22 (40.9%) in group B (P = 0.657).
No signiﬁcant changes in incontinence status, voiding and
storage symptoms emerged since midterm outcomes [8].
Table 2 reported all data comparing medium and long-term
followup. As regards changes of continence status we did not
ﬁnd a signiﬁcant increase of incontinent patients at 5-year
followup: 56.5% of patients in group A were incontinent
(versus 54.2% at mid term followup) and 40.9% of group
B (versus 39.1 at midterm followup). Four patients, with
persistent SUI, underwent midurethral slings and were dry
at the last followup (Table 2).
All group A patients were successfully treated for voiding
dysfunction except for one who developed a rectocele afterObstetrics and Gynecology International 3
Table 1: Demographic and clinical variables of groups A and B. Patient data.
Colposuspension Yes (24 patients) No (23 patients) P
Age (years; mean/range) 60.0 ± 10.6 (35.1–79.0) 62.6 ± 12.8 (26.9–76.4) NS
Menopause (n/%) 18 (75.0) 18(78.3) NS
Previous urogynecological surgery 5 (20.8) 9 (39.1) NS
Hysterectomy 5 (20.8) 8 (34.8) NS
Prolapse repair 4 (16.7) 5 (21.7) NS
SUI surgery 0 (0.0) 2 (8.7) NS
BMI (kg/m2, median/range) 25.6 (20.8–35.2) 27.0 (16.0–31.9) NS
Parity (median/range) 2 (0–3) 2 (1–3) NS
ureterocele stage I 1 (4.2) 4 (17.4)
NS ureterocele stage II 6 (25.0) 8 (34.8)
ureterocele stage III 17 (70.8) 11 (47.8)
Heart diseases (n/%) 2 (8.3) 1 (4.3) NS
Hypertension (n/%) 6 (25.0) 8 (34.8) NS
Hypercholesterolemy (n/%) 4 (16.7) 6 (26.1) NS
Lower limb varices (n/%) 6 (25.0) 3 (13.0) NS
COPD (n/%) 1 (4.2) 2 (8.7) NS
Auto-immune disease (n/%) 2 (8.3) 3 (13.0) NS
Anxiety (n/%) 5 (20.8) 6 (26.1) NS
Diabetes mellitus type 2 (n/%) 2 (8.3) 3 (13.0) NS
Recurrent urinary tract infections 2 (8.3) 3 (13.0) NS
Hypothyroidism (n/%) 1 (4.2) 2 (8.7) NS
Hydronephrosis (n/%) 1 (4.2) 0 (0.0) NS
5 years and showed recurrence of voiding symptoms. One
patient,whohadbeenconsideredcuredofstoragesymptoms
[8], developed them again (Table 2).
In group B no changes were recorded in voiding dys-
function since the previous followup. One patient, who had
been considered cured of storage symptoms [8], developed
them again (Table 2). One patient had developed de novo
storagesymptomsandonehadbecomeincontinentsincethe
previous followup. The results of incontinence treatments
are illustrated in Table 2. Two patients with persistent SUI
underwent midurethral slings and were dry at the last
followup.
Table 3 summarized the followup for the other parame-
ters. Anatomical results had not changed since the previous
followup. Questionnaires and the VAS score at long-term
followups showed excellent results.
4. Discussion
To date no consensus has as yet been reached on whether
or not an anti-incontinence procedure should be performed
concomitantly with POP repair, independently of the pres-
ence or absence of urinary incontinence.
As far as regarding patients with preoperative SUI, BC
might change outcomes, when associated with an abdominal
POP repair, as it will act upon the bladder and urethra to
improve continence. In order to answer we randomized 47
women with POP and UI to abdominal POP repair with
concomitant BC or POP repair alone [8]. At a midterm
followup, BC did not provide any additional beneﬁt in
incontinent patients as 54.2% were still incontinent after
POP with BC compared with 39.1%, who did not receive BC
(P = 0.459) [8]. The present long-term followup conﬁrms
m i d t e r mo u t c o m e .A ta5 - y e a rf o l l o w u p ,B Ci sa s s o c i a t e d
with higher incontinence rate, as previously reported, and
does not add any beneﬁt to urinary function. Our ﬁndings
seem to be in line with data by Cosson et al. who reported
that only 34% of the patients with prolapse and preoperative
SUI achieved complete correction of the urinary dysfunction
with a BC procedure during sacrocolpopexy [15]. When
the Burch is combined with sacrocolpopexy results do not
appearasgoodasthoseofanisolatedBurchprocedurewhich
showsalong-termcurerateof69%after10–12years.Cosson
et al. retain that failure might be due to excessive traction on
the anterior mesh and suggest performing colposuspension
before colpopexy [15]. It is our opinion that abdominal
colpopexy could be more at risk for postoperative SUI
because of the change in the vaginal axis. Even though we
have been performing sacropexy for years without excessive
traction on the vaginal walls, in some predisposed patients
(i.e., those with occult intrinsic sphincter deﬁciency) the
direction of traction alone might be enough to cause SUI.
Applying an adjunctive factor, such as the BC, with an
anterior traction on the bladder neck, may increase the risk
of SUI. Other factors such as surgical damage to urethral4 Obstetrics and Gynecology International
Table 2: Incontinence, voiding, and storage symptoms: long-term followup in groups A and B. Mid- and long-term outcomes.
Group A Group B
Previous
followup:
50 months
Extended
followup:
69 months
Treatment Results
Previous
followup:
46 months
Extended
followup:
63 months
Treatment Results
Incontinent
patients
13/24 13/23 9/23 9/22
8 SUI 7 SUI 9 SUI 6 SUI
4 MUI 4 MUI 3 MUI
1 UUI 2 UUI
Grade 1 UI 66
2F K T
(PFME) Satisﬁed
64
3n o
treatment Satisﬁed
4n o
treatment
Satisﬁed
with 1/pad
die
1 antimus-
carinic
agents
Satisﬁed
Grade 2/3 UI 77
4 MUS Dry
35
2 MUS Dry
1r e f u s e d
surgery
Not
satisﬁed 3 refuse
surgery
Not
satisﬁed
2 antimus-
carinic
agents
Improved
Voiding
symptoms
Cured
17/17
Cured
16/17
No
treatment
Cured
19/21
Cured
18/20 No
treatment
Improved
2
Improved
2
Cured
12/16
Cured
10/15
Cured
15/17
Cured
14/16
Storage
symptoms
Persistent
4
Persistent
5
2 antimus-
carinic
agents
Improved Persistent
2
Persistent
3
2 antimus-
carinic
agents
Improved
De novo 2 De novo 2 De novo 1 De novo 2
sphincter innervation and to the periurethral vascular plexus
might also come into play. Other criticism may be advanced
about BC. BC lengthens the operating time and may be a
source of complications [16].
Recently a mail survey on members of International
Urogynaecological Association investigated the practice pat-
terns in the management of UI and POP [17]. The survey
showed that most IUGA members perform BC as well as
other procedures (i.e., TVT) for surgical therapy of urinary
incontinence with genital prolapse. Borstad et al. compared
the result of TVT performed at the time of prolapse repair or
3monthslaterinwomenwithPOPandSUI,byamulticenter
prospective randomized trial [18]. From over 181 women
with POP and SUI, 87 were randomized to have a TVT
at the time of prolapse repair (group I) and 94 women 3
months later (group II). All the women in group II were
evaluated for SUI 3 months after the prolapse repair and
53 women with conﬁrmed SUI had a TVT performed. They
found that 95% and 89%, respectively, for group I and II,
were cured, but only 27% were cured after prolapse surgery
alone. Although the study was well conducted and the results
valid the followup was short: 1 year. Fujihara et al. reported
their experience in 643 patients who underwent a TVM [19].
The aim of the study was to establish whether concomitant
SUI and cystocele repair or two-stage surgery was the best
solution for patients with cystocele. They showed that 37.9%
of patients who were continent before surgery developed de
novo incontinence and 6.3% underwent TOT 3 months later.
On the other hand TVM cured only 29.7% of patients who
were incontinent preoperatively and 6% needed a TOT after
3 months. The authors concluded by recommending the 2-
stageapproach.Unfortunatelythefollowupisveryshort,and
no long-lasting conclusion may be drawn.
Few studies have addressed changes in storage and
voiding bladder symptoms after abdominal CSP with or
without BC at a long-term followup. In women without SUI
Burgio and colleagues found that preoperative storage and
voiding symptoms improved independently of BC although
BC seemed to reduce urgency [20]. In our series we found
a signiﬁcant improvement of symptoms throughout groups
aftersurgeryafterameanfollowupof3years.Asweextended
our mean followup to a minimum of 6 years with a median
of 80 months, we did not ﬁnd any signiﬁcant diﬀerences
or changes in the lower urinary tract symptoms whether
patients received BC or not.
The present study contains inherent weaknesses. There
is admittedly a signiﬁcant risk of a type II error, which
meanssayingthereis“nodiﬀerence”whenadiﬀerenceexists.Obstetrics and Gynecology International 5
Table 3: Secondary outcome end-points in patients of group A and B. Outcomes after mid- and long-term followups.
Yes colposuspension (group A) No colposuspension (group B) Pre Post
Before (24) P After (23) Before (23) P After (22) A versus B group A versus B group
Anatomical Results 24 <0.001
22 3 <0.001 3
2s t a g eIr e c t o c e l e s
2s t a g eI
rectoceles
—N S
1S t a g eI I
rectocele
No sexual
intercourse
5 NS 7 10 NS 9 NS NS
Disturbances during
sexual intercourse
10 0.023 3 8 NS 4 NS NS
No disturbances
during sexual
intercourse
9N S 1 3 5N S 9 NS NS
Constipation 11 0.046 3 persistent 9N S 2 persistent NS NS
1 ex novo 1 ex novo
IIQ7
(median/range)
16 (3–35) <0.001 1 (0–11) 18 (1–45) <0.001 2 (0–17) NS NS
UDI6
(median/range)
16 (6–45) <0.001 3 (0–10) 16 (0–43) <0.001 2.5 (0–14) NS NS
VAS (median/range) 8 (4–10) 8.5 (5–10) NS
Patients would not
repeat surgery
3 3 NS
Re-interventions for
UI
4(MUS) 2( M U S ) NS
VAS: Visual Analogue Scale.
MUS: Mediourethral sling.
The sample size might appear grossly inadequate for the
hypothesis understudy and we are, in fact, aware it is
suﬃcient only to detect large diﬀerences that would be
biologically unexpected given the hypothesis understudy.
Finally, although surgeons were not blinded, the staﬀ that
evaluated outcome did not know what the type of surgery
the patient had undergone. This form of blinding may serve
to minimize the risk of detection bias, which is known as
observer, ascertainment, or assessment bias. Consequently,
we realize that any conclusions might be questionable.
However, even though acknowledging the study limitations
mightprejudicepublication,webelievethatourresultsatthe
end of such a long followup make a worthy contribution to
an ongoing debate on what to do when treating patients with
concomitant UI and POP.
5. Conclusion
When we extended the followup of our randomized con-
trolled trial, results cast doubts on whether BC should be
performed during POP repair in incontinent women. We
found that in incontinent women BC did not add signiﬁcant
improvement. Further studies remain mandatory in order to
conﬁrm our long-term results and to investigate alternative
anti-incontinence procedures.
Abbreviation
BC: Burch colposuspension
B&W: Baden & Walker
CSP: Colposacropexy
ICS: International Consultation on Incontinence
IIQ: Incontinence impact on quality of life
PASW: Predictive Analytic Software
POP: Pelvic organ prolapse
POP-Q: Pelvic organ prolapse quantiﬁcation
QoL: Quality of life
SUI: Stress urinary incontinence
TVM: Tension-free vaginal mesh procedure
TVT: Tension-free vaginal tape
UDI: Urogenital distress inventory
UI: Urinary incontinence
VAS: Visual analogue scale
VLPP: Valsalva leak point pressure.
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